OTCMKTS:TSMRF Tsumura & Co. (TSMRF) Stock Price, News & Analysis $23.20 0.00 (0.00%) As of 10/30/2026 Add Compare Share Share Stock Analysis Stock AnalysisChartNews and Trends About Tsumura & Co. Stock (OTCMKTS:TSMRF) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Tsumura & Co. alerts:Sign Up Key Stats Today's Range$22.71▼$23.2050-Day Range$23.20▼$23.2052-Week Range$23.20▼$25.75VolumeN/AAverage Volume400 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Tsumura & Co. is a Japan-based pharmaceutical company specializing in Kampo medicines, traditional Japanese formulations derived from classical Chinese herbal medicine. The company develops, manufactures, and markets prescription Kampo products, primarily in the form of standardized herbal extracts used by healthcare professionals in Japan. Its product portfolio is made from medicinal plants and other crude drug ingredients sourced, processed, and formulated under pharmaceutical quality standards. Tsumura also offers over-the-counter herbal medicines and related products, while conducting research into the clinical applications and quality control of Kampo therapies. The company traces its origins to 1893, when it began operating as a manufacturer of traditional medicines, and it has played a significant role in the modernization and broader medical use of Kampo in Japan. Its principal market is Japan, where Kampo products are integrated into the healthcare system, although the company also maintains business activities and supply-chain operations connected with China and other international markets.AI Generated. May Contain Errors. Read More Receive TSMRF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Tsumura & Co. and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. TSMRF Stock News HeadlinesTsumura Lifts Earnings Forecast on Yomeishu Deal Despite China WeaknessOctober 28, 2026 | tipranks.comTsumura Takes Yomeishu Seizo Private to Boost OTC and Preventive HealthcareSeptember 1, 2026 | tipranks.comFederal Reserve Reveals Disturbing New Plan To Control Your MoneyDocket No. OP-1670 is drawing attention for what it reveals about the Federal Reserve's next move. Buried on page 84 is a plan that could expand oversight of checking accounts, purchases, and money transfers across the country. Martin D. Weiss, PhD, founder of Weiss Ratings, breaks down what this document means and why it could roll out as soon as this summer.November 2 at 1:00 AM | Weiss Ratings (Ad)Tsumura Appoints COO Kei Sugii as Additional Representative Director to Bolster ManagementJune 25, 2026 | tipranks.comTsumura to Take Yomeishu Private in ¥6.8 Billion Multi-Stage Deal to Expand Healthcare PortfolioFebruary 24, 2026 | tipranks.comTsumura Aligns Yomeishu Share Acquisition With Long-Term Kampo Healthcare VisionFebruary 24, 2026 | tipranks.comTsumura Updates Q3 FY2026 Results and Expands Consolidation of Chinese Herbal SubsidiaryFebruary 5, 2026 | tipranks.comTsumura Confirms It Is Weighing Reported Yomeishu Take-Private but Says No Decision YetFebruary 2, 2026 | tipranks.comSee More Headlines TSMRF Stock Analysis - Frequently Asked Questions How have TSMRF shares performed this year? Tsumura & Co.'s stock was trading at $23.20 at the beginning of the year. Since then, TSMRF shares have increased by 0.0% and is now trading at $23.20. How do I buy shares of Tsumura & Co.? Shares of TSMRF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today11/02/2026Next Earnings (Estimated)11/09/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolOTCMKTS:TSMRF CIKN/A Webwww.tsumura.co.jp Phone81 3 6361 7101FaxN/AEmployees4,032Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Energy Stocks to Buy and Hold ForeverOil still powers the global economy, but AI is reshaping the energy opportunity. Discover seven stocks spanning traditional energy, infrastructure, and next-generation power.Get This Free Report This page (OTCMKTS:TSMRF) was last updated on 10/30/2026 by MarketBeat.com Staff. From Our PartnersI'm handing you this one freeElon Musk doesn't own the chip powering every Tesla, every Starlink dish, and every AI satellite he builds, he...Behind the Markets | SponsoredMy public warning after 55 years of watching the marketsDr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | SponsoredNEVER thought this would happen againTwenty five years ago, this analyst predicted the fiber optic boom and called Amazon before it became a househ...Porter & Company | SponsoredDoes your nest egg have an expiration date?A $250,000 nest egg growing at 5% a year and paying out $2,500 a month runs dry in just over a decade. Start w...Investors Alley | SponsoredElon Musk about to bankrupt Amazon, Microsoft & Google?Jeff Brown, the former tech executive who called the rise of Bitcoin, Tesla, and Nvidia years early, is tracki...Brownstone Research | SponsoredLast call for your free 0DTE reportThe 0DTE Game Plan lays out a simple 3-step framework for trading same-day options: Plan it, profit from it, p...Profits Run | SponsoredTrump’s issues shocking Executive Order on U.S. DollarThree days into his second term, President Trump signed Executive Order 14178 a move the press barely covered....Banyan Hill Publishing | SponsoredBank of America: 'Digital Dollar Inevitable'Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tsumura & Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tsumura & Co. With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
